Regionshospital Nordjylland
- Address
- lock Available on a paid plan
Cardiovascular Diseases
At Regionshospital Nordjylland the Department of Anesthesiology and Intensive Care is conducting studies aimed at improving outcomes for patients with cardiovascular conditions. Trials are testing novel agents to lower the risk of death or hospitalization in chronic heart failure and to prevent stroke in people with atrial fibrillation. Research also explores rapid‑response treatments during in‑hospital cardiac arrest to increase survival rates.
- ASCVD – Atherosclerotic Cardiovascular Disease
- Chronic Heart Failure With Reduced Ejection Fraction
- In‑hospital cardiac arrest
- Prevention of stroke or systemic embolism in atrial fibrillation
With a team of 11 investigators, the site is contributing valuable data to the global effort against heart disease.
Immune System Processes
The department is also active in pediatric infectious‑disease research, focusing on protection against respiratory syncytial virus (RSV). A vaccine‑based study evaluates safety and the ability to prevent medically attended lower respiratory infections in infants.
- Prevention of RSV in healthy infants
Based in Hjørring, Denmark, the centre collaborates with international partners to accelerate vaccine development.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 6 therapeutic areas and 15 of 55 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1GlaxoSmithKline Biologicals2active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Merck Sharp & Dohme LLC4trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 111 other sites in Denmark
Therapeutic Area Benchmark — Denmark
Select a therapeutic area to compare against other sites in Denmark.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Denmark
Market Share
Country: Denmark
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Regionshospital Nordjylland
lock Showing 1 of 19 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants | Merck Sharp & Dohme LLC | Phase IV | Not Recruiting | Nov 2022 | Feb 2024 |
IMP list
lock Showing 1 of 55 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| GSKVX000000025896 | 2 | Unknown | 2025-12-10 | 2025-12-10 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.